• No results found

Experimental Study on Shear Strengthening of R C Beams Using Nylon Textile-Reinforced Mortar

N/A
N/A
Protected

Academic year: 2020

Share "Experimental Study on Shear Strengthening of R C Beams Using Nylon Textile-Reinforced Mortar"

Copied!
8
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1. Test Specimens
Fig. 2. Detailing of Test beams (a) Control Beam(b) Beams with 0/90(d) 0 textile orientation (c) Beams with 450 textile orientation (d) Cross section of beams
Fig. 3. Casting of specimen (a) Casting of RC Beam(b) Cleaning and chipping of beam surface(c) Wrapping of Nylon textile(d)Applying Mortar
Fig. 4.Test set up for beam specimen
+3

References

Related documents

Recommendation 5: IDOE should identify the assessment design and anticipated testing time for the 2016 ISTEP+ program and release this information publicly this spring to

Regional pulmonary response to a methacholine challenge using hyperpolarized (3)He magnetic resonance imaging. The impact of temporal inaccuracies on 4DCT image quality. The impact

This comparative static result obtained under nonlinear constraint (discounted price) is not the same result under linear constraint (linear price) obtained by Moolio et al

Consist- ently, ectopic expression of STARD13-correlated ceRNAs-3 ′ UTRs in breast cancer cells elevated LATS1/ 2 levels, while the knockdown of STARD13-correlated ceRNAs

The aims of this study are to (1) determine the feasibility of conducting a definitive phase 3 randomised trial, which evaluates effectiveness of STEP Care (compared to usual

African perspective of organizational ethics also revolves around ethical systems, written and/or unwritten guidelines, ethical values, principles, rules and standards, drawn from

This report includes the investi- gation of structural modification as a function of compo- sition by quantitative FTIR and UV-Vis Diffused Ref- lectance Spectroscopy (UV-Vis-DRS)

Quality of Artemisinin-Based Combination Formulations for Malaria Treatment: Prevalence and risk factors for poor quality medicines in public facilities and private sector drug